Physician Resources
Collapse Bowel Resection in Gynecologic Cancer: From Fundamentals to Mastery Webinar

This webinar focuses on foundational principles of safe and effective bowel resection in gynecologic oncology surgery. Content includes technical specifications for equipment with a focus on bowel staplers, important anatomic considerations, and fundamental steps of small bowel resection, rectosigmoid resection and associated anastomoses. Troubleshooting, common pitfalls and pearls of wisdom from experts are presented.

This webinar is targeted to the junior surgeon who desires more confidence in these procedures and for the senior surgeon who desires a review of the tenets associated with high surgical quality.

Presenters:
Ahmed Al-Niaimi, MD, FACOG, FACS, Associate Professor, Director of Surgical Quality, Gynecologic Oncology Surgery, Department of OBGYN, University of Wisconsin

Robert Bristow, MD, MBA, Chair, Gynecologic Oncology, Professor, Obstetrics & Gynecology, School of Medicine, University of California, Irvine

 

Live webinar recorded on Jan. 21, 2021. 

Formats Available: On-Demand
Original Series Date: January 21, 2021
Register &
More InfoRegister & <br />More Info Bowel Resection in Gynecologic Cancer: From Fundamentals to Mastery Webinar
Collapse Chemotherapy & Targeted Therapy Flash Cards

These cards highlight therapies which may be used less frequently and offer a “refresher” on dosing, side effects, contraindications, and more. Flash cards are available as printable PDFs for quick reference in-clinic. 

Formats Available: Online Materials
Original Series Date: October 26, 2020
Register &
More InfoRegister & <br />More Info Chemotherapy & Targeted Therapy Flash Cards
Collapse NCI Grants for Training & Career Development

A brief introduction to the different fellowship, career development and training grant types offered by NCI is followed by more in depth description of the K12, K08 and K99 mechanisms which are suitable for clinician scientists. In the second part of the presentation, the characteristics of a competitive application are discussed with advice on how to write one. Lastly, the places where you can find more information on NCI and NIH websites are provided.

Formats Available: On-Demand
Original Series Date: August 13, 2020
Register &
More InfoRegister & <br />More Info NCI Grants for Training & Career Development
Collapse NEW! APP Onboarding Tool

This resource is free and only available to SGO Members. You must sign in before "purchasing" this product (for $0.00) to confirm your membership. 

This tool, designed as a resource to aid in the onboarding process of Advanced Practice Providers (APPs) new to a gynecology oncology practice, was developed by the SGO APP Committee, with additional input from physicians on the SGO Education Committee. The tool is a useful guide applicable for APPs practicing in both clinic and inpatient settings. 

Formats Available: SGO APP Onboarding Tool
Original Series Date: October 20, 2020
On-Demand Release Date: Available Now
Register &
More InfoRegister & <br />More Info NEW! APP Onboarding Tool
Collapse PARP Inhibitors in Gynecologic Oncology: Management and Treatment of Side Effects in Practice

This slide deck contains useful tips for managing PARP side effects when used to treat gynecologic cancers. This is a printable document that can be downloaded for use in-clinic or viewed on a desktop or mobile device. 

Formats Available: Slide Deck Download
Original Series Date: July 22, 2019
Register &
More InfoRegister & <br />More Info PARP Inhibitors in Gynecologic Oncology: Management and Treatment of Side Effects in Practice
Collapse SGO Journal Club: Controversial Topics in Gynecologic Cancer: Heated Intraperitoneal Chemotherapy

Heated intraperitoneal chemotherapy (HIPEC) at the time of tumor debulking for ovarian cancer has at least one randomized prospective trial demonstrating benefit in overall survival. There is conflicting data as to the approach and timing of HIPEC. Concerns exist regarding toxicity and complexity of use. Significant heterogeneity exists amongst providers whether HIPEC is even discussed as a treatment option with patients. This session will address the pro's and con's of HIPEC to provide clarity on its current role.


Moderators:
Susan Zweizig, MD, UMass Memorial Health Care
Renata Urban, MD, University of Washington

Discussants:
Chad Michener, MD, Cleveland Clinic
Michael McHale, MD, University of California San Diego Health

Formats Available: SGO Journal Club February 2021
Original Series Date: February 24, 2021
Register &
More InfoRegister & <br />More Info SGO Journal Club: Controversial Topics in Gynecologic Cancer: Heated Intraperitoneal Chemotherapy
Collapse The Big Reveal: 2020 State of the Society Survey- Patterns, Progress and Pathways to your Professional Future

With an ever-changing landscape of gynecologic oncology, what are the latest trends in patient care and the profile of a women’s health care provider? SGO’s five-year benchmarking survey now includes input from gynecologic oncologists, advanced practice providers and international members. Hear from SGO past president, Barbara Goff, MD, and David Kushner, MD, on how the top findings from the survey translate into valuable practice implications.

 

 

 

AMA Credit Designation Statement – Physicians
The Society of Gynecology Oncology designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation on each activity.

ANCC Credit Designation Statement – Nurses
This activity has been approved for a maximum of 1.0 nursing contact hours.

PAs may claim a maximum of 1.0 AMA PRA Category 1 Credits™ for completing this live activity. NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state or medical society.

ACPE credit for pharmacists is not offered for this activity.

 

 

In order to assure the highest quality CE programming, SGO requires those who have the opportunity to affect the content of an educational activity to disclose financial relationship(s) with corporate interest(s). This condition must be met prior to participating in the CE activity. All conflicts of interest will be resolved prior to the start of the activity, per the SGO Conflict of Interest Resolution Policy. The following have indicated that no potential conflict(s) of interest exist.

 

Leslie Boyd, MD

Lee-may Chen, MD

Linus Chuang, MD

Barbara Goff, MD

Melissa Hardesty, MD

David Kushner, MD

Jason Lachance, MD

Joanne Rash, MPAS, PA-C

Shitanshu Uppal, MD, MBBS

Susan Zweizig, MD

 

The following have reported a relationship with a corporate interest, as listed, that may result in a conflict of interest. All potential conflict(s) of interest have been resolved through SGO’s Conflict of Interest Resolution Policy:

 

Elisabeth Diver, MD

Clovis Oncology/Advisory board member fee/Advisory board member

GlaxoSmithKline/advisory board fee; clinical trial funding/advisory board participation; site PI for national clinical trial

Aravive, Inc./ clinical trial funding/site PI for national clinical trial

Christina Annunziata, MD

Precision Biologics/Research grant/Principal Investigator

MaxCyte/Research grant/Principal Investigator

Robert  Holloway, MD

Astra Zeneca/speaker fee/Speaker

Clovis/speaker fee, consultant fee/speaker, consultant

GSK/speaker fee/speaker fee, advisory board

Abbvie/ speaker fee/speaker, advisor

Bard-Davol/speaker fee /speaker

BJ Rimel, MD

Tesaro/GSK/consulting fee/Advisory board member

 

Formats Available: On-Demand
Original Series Date: June 25, 2020

Approved Credit:
  • ACCME: 1 hour AMA PRA Category 1 Credit(s)
  • AAPA: 1 hour Category 1 CME
  • ANCC: 1 hour Contact Hour

  • Register &
    More InfoRegister & <br />More Info The Big Reveal: 2020 State of the Society Survey- Patterns, Progress and Pathways to your Professional Future